We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Employment Tribunal decision.
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
Options to support promotions and marketing campaigns, from short URLs to standalone websites.
Two papers from the CMA's Behavioural Hub discussing and summarising evidence on online choice architecture (OCA) and how it potentially causes harm.
Find out what you should consider before using an umbrella company to make sure it complies with the tax rules.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Response issued: 08/10/19
Businessman applied for two Bounce Back Loans and failed to disclose existence of first loan to liquidators
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).